Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medipense is a Canadian private medical device and digital health company focused on medication adherence and remote patient monitoring. Its core product, RxPense, is a connected automated pill-dispensing system designed for seniors, chronic care patients, disabled veterans, and other patients with complex medication regimens. The system combines secure hardware, cloud software, mobile applications, and caregiver/provider workflows to help ensure the right medications are taken at the right time while generating an audit trail of adherence events. Medipense positions RxPense for use across residences, long-term care facilities, rehab centers, pharmacies, hospitals, and home settings. The company appears to be commercial-stage rather than a therapeutics developer, with business activity centered on medication management infrastructure rather than a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medipense.